Segment Information (Tables)
|
9 Months Ended |
Sep. 30, 2022 |
Segment Reporting [Abstract] |
|
Schedule of reportable business segment information |
Reportable business segment information is as follows (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
|
2022 |
|
2021 |
|
2022 |
|
2021 |
Net sales: |
|
|
|
|
|
|
|
Asia |
$ |
47,878 |
|
|
$ |
48,417 |
|
|
$ |
141,370 |
|
|
$ |
127,708 |
|
Europe |
19,328 |
|
|
21,813 |
|
|
58,204 |
|
|
65,468 |
|
North America |
31,504 |
|
|
37,738 |
|
|
101,567 |
|
|
112,872 |
|
Latin America and Other |
5,796 |
|
|
6,778 |
|
|
18,020 |
|
|
20,097 |
|
Total net sales |
104,506 |
|
|
114,746 |
|
|
319,161 |
|
|
326,145 |
|
|
|
|
|
|
|
|
|
Contribution margin (1): |
|
|
|
|
|
|
|
Asia |
21,268 |
|
|
21,421 |
|
|
64,639 |
|
|
55,203 |
|
Europe |
7,189 |
|
|
6,959 |
|
|
18,157 |
|
|
20,343 |
|
North America |
10,839 |
|
|
17,193 |
|
|
35,858 |
|
|
48,892 |
|
Latin America and Other |
2,508 |
|
|
3,961 |
|
|
7,703 |
|
|
11,355 |
|
Total contribution margin |
41,804 |
|
|
49,534 |
|
|
126,357 |
|
|
135,793 |
|
|
|
|
|
|
|
|
|
Selling, general and administrative expenses (2) |
36,792 |
|
|
39,528 |
|
|
114,281 |
|
|
108,666 |
|
Operating income |
5,012 |
|
|
10,006 |
|
|
12,076 |
|
|
27,127 |
|
|
|
|
|
|
|
|
|
Other loss, net |
(2,281) |
|
|
(886) |
|
|
(3,037) |
|
|
(2,290) |
|
Income before provision for income taxes |
$ |
2,731 |
|
|
$ |
9,120 |
|
|
$ |
9,039 |
|
|
$ |
24,837 |
|
_________________________________________
(1) Contribution margin consists of net sales less cost of sales and volume incentives expense. (2) Service fees in China totaled $2.5 million and $11.3 million for the three and nine-month periods ended September 30, 2022, respectively, compared to $5.2 million and $11.7 million for the three and nine-month periods ended September 30, 2021. These service fees are included in selling, general and administrative expenses.
|
Schedule of consolidated net sales revenue by geographical locations |
From an individual country/region perspective, the United States, South Korea and Taiwan comprise 10 percent or more of consolidated net sales for the three and nine-month periods ended September 30, 2022 and 2021, as follows (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
|
2022 |
|
2021 |
|
2022 |
|
2021 |
Net sales: |
|
|
|
|
|
|
|
United States |
$ |
29,077 |
|
|
$ |
34,960 |
|
|
$ |
93,789 |
|
|
$ |
104,258 |
|
South Korea |
14,967 |
|
|
15,985 |
|
|
43,085 |
|
|
48,340 |
|
Taiwan |
13,465 |
|
|
7,361 |
|
|
35,148 |
|
|
14,860 |
|
Other |
46,997 |
|
|
56,440 |
|
|
147,139 |
|
|
158,687 |
|
|
$ |
104,506 |
|
|
$ |
114,746 |
|
|
$ |
319,161 |
|
|
$ |
326,145 |
|
|
Schedule of revenue generated by each of the Company's product lines |
Net sales generated by each of our product lines is set forth below (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
|
2022 |
|
2021 |
|
2022 |
|
2021 |
Asia |
|
|
|
|
|
|
|
General health |
$ |
14,705 |
|
|
$ |
13,150 |
|
|
$ |
40,010 |
|
|
$ |
37,140 |
|
Immune |
654 |
|
|
463 |
|
|
2,779 |
|
|
1,048 |
|
Cardiovascular |
14,626 |
|
|
13,018 |
|
|
41,498 |
|
|
35,181 |
|
Digestive |
8,599 |
|
|
10,427 |
|
|
28,625 |
|
|
25,045 |
|
Personal care |
2,758 |
|
|
4,201 |
|
|
7,384 |
|
|
12,015 |
|
Weight management |
6,536 |
|
|
7,158 |
|
|
21,074 |
|
|
17,279 |
|
|
47,878 |
|
|
48,417 |
|
|
141,370 |
|
|
127,708 |
|
Europe |
|
|
|
|
|
|
|
General health |
$ |
8,638 |
|
|
$ |
9,308 |
|
|
$ |
25,162 |
|
|
$ |
28,447 |
|
Immune |
1,899 |
|
|
2,285 |
|
|
5,973 |
|
|
6,119 |
|
Cardiovascular |
2,385 |
|
|
2,774 |
|
|
7,168 |
|
|
8,602 |
|
Digestive |
4,849 |
|
|
5,700 |
|
|
14,921 |
|
|
16,807 |
|
Personal care |
1,087 |
|
|
1,167 |
|
|
3,529 |
|
|
3,592 |
|
Weight management |
470 |
|
|
579 |
|
|
1,451 |
|
|
1,901 |
|
|
19,328 |
|
|
21,813 |
|
|
58,204 |
|
|
65,468 |
|
North America |
|
|
|
|
|
|
|
General health |
$ |
14,241 |
|
|
$ |
16,573 |
|
|
$ |
44,509 |
|
|
$ |
49,192 |
|
Immune |
3,546 |
|
|
5,056 |
|
|
12,479 |
|
|
14,031 |
|
Cardiovascular |
3,427 |
|
|
4,171 |
|
|
11,162 |
|
|
12,406 |
|
Digestive |
8,096 |
|
|
9,079 |
|
|
25,734 |
|
|
28,558 |
|
Personal care |
1,397 |
|
|
1,978 |
|
|
4,961 |
|
|
5,631 |
|
Weight management |
797 |
|
|
881 |
|
|
2,722 |
|
|
3,054 |
|
|
31,504 |
|
|
37,738 |
|
|
101,567 |
|
|
112,872 |
|
Latin America and Other |
|
|
|
|
|
|
|
General health |
$ |
1,597 |
|
|
$ |
1,959 |
|
|
$ |
5,012 |
|
|
$ |
5,807 |
|
Immune |
709 |
|
|
806 |
|
|
2,225 |
|
|
2,314 |
|
Cardiovascular |
438 |
|
|
448 |
|
|
1,250 |
|
|
1,351 |
|
Digestive |
2,569 |
|
|
2,941 |
|
|
7,961 |
|
|
8,813 |
|
Personal care |
329 |
|
|
406 |
|
|
1,050 |
|
|
1,149 |
|
Weight management |
154 |
|
|
218 |
|
|
522 |
|
|
663 |
|
|
5,796 |
|
|
6,778 |
|
|
18,020 |
|
|
20,097 |
|
|
$ |
104,506 |
|
|
$ |
114,746 |
|
|
$ |
319,161 |
|
|
$ |
326,145 |
|
|
Schedule of consolidated property, plant and equipment by geographical locations |
From an individual country perspective, only the United States comprised 10 percent or more of consolidated property, plant and equipment as follows (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, 2022 |
|
December 31, 2021 |
Property, plant and equipment: |
|
|
|
United States |
$ |
43,886 |
|
|
$ |
46,595 |
|
Other |
3,468 |
|
|
4,262 |
|
Total property, plant and equipment, net |
$ |
47,354 |
|
|
$ |
50,857 |
|
|
Schedule of assets per segment |
Total assets per segment is set forth below (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, 2022 |
|
December 31, 2021 |
Assets: |
|
|
|
Asia |
$ |
89,570 |
|
|
$ |
104,659 |
|
Europe |
16,872 |
|
|
15,486 |
|
North America |
110,087 |
|
|
131,207 |
|
Latin America and Other |
6,979 |
|
|
7,522 |
|
Total assets |
$ |
223,508 |
|
|
$ |
258,874 |
|
|